The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Italy's health minister asks to use Astrazeneca vaccine for over 65s

Fri, 05th Mar 2021 10:18

MILAN, March 5 (Reuters) - Italy has asked to verify whether
it was possible to extend the use of Astrazeneca's
COVID-19 vaccine to people over the age of 65, a spokesman for
the health minister said on Friday.

When the AstraZeneca vaccine was approved for use by EU
regulators earlier this year, many EU countries including
France, Germany and Italy said it should not be given to the
elderly, citing a lack of sufficient data.

But France and others, which lag far behind Britain with
their vaccination campaigns, have also now moved to allow their
elderly citizens to receive AstraZeneca shots following a
Scottish study, which showed a markedly reduced risk of a
serious course of illness from COVID-19 across all age groups
following vaccination.
(Reporting by Angelo Amante, writing by Maria Pia Quaglia,
editing by Agnieszka Flak)

Related Shares

More News
Today 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Today 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.